Innoviva (INVA) Change in Account Payables (2010 - 2026)
Innoviva (INVA) posted Change in Account Payables of $1.6 million for Q1 2026, down 62.25% on a QoQ basis from $4.1 million in Q3 2025, and down 39.56% year-over-year from $2.6 million in Q1 2025.
Innoviva (INVA) Change in Account Payables (2010 - 2026) Analysis & Trends
Innoviva's Change in Account Payables history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- Quarterly Change in Account Payables fell 39.56% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (up 291.39% YoY) and the FY2025 annual result came in at $2.8 million, up 161.81% from the prior year.
- Change in Account Payables was $1.6 million for Q1 2026 at Innoviva, down from $4.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.1 million in Q3 2025 and bottomed at -$5.8 million in Q1 2024.
- A 5-year average of $604307.7 and a median of $958000.0 in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 15618.75% — and 2024, when it sank 401.78%.
- Innoviva's Change in Account Payables stood at $958000.0 in 2022, then retreated by 11.9% to $844000.0 in 2023, then sank by 401.78% to -$2.5 million in 2024, then surged by 261.41% to $4.1 million in 2025, then tumbled by 62.25% to $1.6 million in 2026.
- Business Quant data shows INVA's Change in Account Payables at $1.6 million in Q1 2026, $4.1 million in Q3 2025, and $682000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 1.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Sep 30, 2025 | 4.11 Mn |
| Sep 30, 2025 | 4.11 Mn |
| Jun 30, 2025 | 682,000.00 |
| Jun 30, 2025 | 682,000.00 |
| Mar 31, 2025 | 2.57 Mn |
| Mar 31, 2025 | 2.57 Mn |
| Sep 30, 2024 | -2.55 Mn |
| Sep 30, 2024 | -2.55 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | -5.83 Mn |
| Mar 31, 2024 | -5.83 Mn |
| Sep 30, 2023 | 844,000.00 |
| Sep 30, 2023 | 844,000.00 |
| Jun 30, 2023 | -1.34 Mn |
| Jun 30, 2023 | -1.34 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Mar 31, 2023 | 2.99 Mn |